947759-58-2

Upstream product

• 1256376-22-3 (2S,3S,4R)-1-O-(2',3',4',6'-tetra-O-benzyl-α-D-galactopyranosyl)-2-azido-3,4-di-tert-butyldimethylsilyloxyoctadecane 

Downstream Products

• 1082746-11-9 C₇₄H₁₁₃NO₁₀SSi₂ 
• 1082746-10-8 C₇₃H₁₁₁NO₁₀SSi₂ 
• 947759-65-1 C₈₀H₁₃₃NO₁₀SSi₂ 
• 947759-63-9 C₇₁H₁₀₇NO₁₀SSi₂ 
• 1082746-13-1 C₇₀H₁₀₄FNO₁₀SSi₂ 
• 1082746-07-3 C₇₄H₁₀₇NO₁₀SSi₂ 
• 1082746-09-5 C₇₆H₁₀₉NO₁₀SSi₂ 
• 1082746-15-3 C₆₅H₁₀₃NO₁₀SSi₂ 
• 1082746-06-2 C₇₀H₁₀₅NO₁₀SSi₂ 
• 947759-59-3 C₇₁H₁₀₇NO₁₀SSi₂ 
• 1082746-08-4 C₇₁H₁₀₇NO₁₁SSi₂ 
• 1082746-12-0 C₇₂H₁₀₈N₂O₁₁SSi₂ 
• 947759-60-6 C₅₉H₇₉NO₁₀S 
• 947759-50-4 (2S,3S,4R)-1-(α-D-galactopyranosyloxy)-2-(p-toluenesulfonylamino)-3,4-octadecanediol 

Relevant academic research and scientific papers

Asymmetric synthesis of the α-D-galactosyl ceramide KRN7000 via an organocatalytic aldol reaction as key step

The asymmetric synthesis of the antitumor and immunostimulatory α-D-galactosyl ceramide KRN7000 using a (R)-proline-catalyzed enantioselective aldol reaction as key step is described. The title compound is synthesized in thirteen linear steps with excelle